About 300 drugs are in short supply and several of them are cancer drugs. The shortage has become a life-threatening situation for cancer patients since many of the drugs they need have no substitutions. The Biden administration has created a team to find a long-term fix for drug shortages. Plans being considered include tax incentives for generic drug makers along with increased transparency concerning generic drug quality. Part of the FDA’s solution includes requiring drugmakers to give the agency advance notice about potential drug shortages and the reasons behind the problem.

Source: New York Times June 02, 2023 01:27 UTC